Gilead Sciences promotes Alex Kalomparis
Published
He replaces Amy Flood, who exited the company after 21 years to join Corcept Therapeutics, as SVP of public affairs.
Full ArticlePublished
He replaces Amy Flood, who exited the company after 21 years to join Corcept Therapeutics, as SVP of public affairs.
Full Article